Healthcare provider profile · identity verified

Constance B Simons, FNP

Nurse Practitioner · HOLLY HILL, SC · NPI 1740496165

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	514	122
Rosuvastatin Calcium	Rosuvastatin Calcium	435	113
Atorvastatin Calcium	Atorvastatin Calcium	401	106
Losartan Potassium	Losartan Potassium	258	61
Levothyroxine Sodium	Levothyroxine Sodium	245	55
Omeprazole	Omeprazole	245	66
Trazodone Hcl	Trazodone Hcl	222	47
Duloxetine Hcl	Duloxetine Hcl	186	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	183	49
Pantoprazole Sodium	Pantoprazole Sodium	182	45
Fluticasone Propionate	Fluticasone Propionate	179	59
Metformin Hcl Er	Metformin Hcl	176	39
Alprazolam	Alprazolam	165	25
Gabapentin	Gabapentin	161	47
Metoprolol Succinate	Metoprolol Succinate	142	35
Hydrochlorothiazide	Hydrochlorothiazide	137	28
Furosemide	Furosemide	125	33
Glimepiride	Glimepiride	122	23
Sertraline Hcl	Sertraline Hcl	119	28
Carvedilol	Carvedilol	118	26
Fluoxetine Hcl	Fluoxetine Hcl	116	23
Meloxicam	Meloxicam	116	25
Allopurinol	Allopurinol	113	20
Lisinopril	Lisinopril	111	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	105	29
Simvastatin	Simvastatin	102	28
Jardiance	Empagliflozin	99	15
Zolpidem Tartrate	Zolpidem Tartrate	96	14
Olmesartan Medoxomil	Olmesartan Medoxomil	95	19
Tramadol Hcl	Tramadol Hcl	92	19
Tamsulosin Hcl	Tamsulosin Hcl	91	23
Albuterol Sulfate Hfa	Albuterol Sulfate	90	28
Pravastatin Sodium	Pravastatin Sodium	89	19
Celecoxib	Celecoxib	86	18
Mirtazapine	Mirtazapine	82	21
Ozempic	Semaglutide	80	suppressed
Montelukast Sodium	Montelukast Sodium	75	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	75	14
Paroxetine Hcl	Paroxetine Hcl	73	12
Meclizine Hcl	Meclizine Hcl	67	20
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	67	16
Clonazepam	Clonazepam	64	suppressed
Metformin Hcl	Metformin Hcl	64	24
Famotidine	Famotidine	63	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	63	26
Bupropion Xl	Bupropion Hcl	58	13
Diclofenac Sodium	Diclofenac Sodium	57	24
Potassium Chloride	Potassium Chloride	55	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	14
Escitalopram Oxalate	Escitalopram Oxalate	53	11
Colchicine	Colchicine	48	14
Amitriptyline Hcl	Amitriptyline Hcl	46	suppressed
Januvia	Sitagliptin Phosphate	46	suppressed
Mounjaro	Tirzepatide	46	12
Pregabalin	Pregabalin	46	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	44	13
Rybelsus	Semaglutide	42	suppressed
Chlorthalidone	Chlorthalidone	41	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	41	suppressed
Eliquis	Apixaban	40	suppressed
Linzess	Linaclotide	38	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	11
Spironolactone	Spironolactone	35	11
Alendronate Sodium	Alendronate Sodium	34	suppressed
Clonidine Hcl	Clonidine Hcl	34	suppressed
Lorazepam	Lorazepam	34	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Trulicity	Dulaglutide	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	27	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	26	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	26	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Diazepam	Diazepam	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Atenolol	Atenolol	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Baclofen	Baclofen	18	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Topiramate	Topiramate	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Temazepam	Temazepam	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Finasteride	Finasteride	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Lovastatin	Lovastatin	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error